Vote Scores
Filings read through

Prime Medicine, Inc.: how funds voted at the meeting of 1 Aug 2025

Ticker
PRME
Meeting
Season
year to 30 June 2026
Filers reporting
55
Ballot items
4

55 filers on Form N-PX reported votes at the Prime Medicine, Inc. meeting of 1 Aug 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    1 vote record from 1 filer. No filer marked the item for or against management. 1 filer gave no management mark.

  2. Item 2: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    4 vote records from 3 filers. 3 of the 3 filers that marked the item voted against management.

    • Positions of one fund family
    • Against 1
    • Against management 1
  3. Item 3: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    89 vote records from 51 filers. 39 of the 47 filers that marked the item voted against management. 4 filers gave no management mark.

    • Positions of 25 fund families
    • For 3
    • Against 22
    • Against management 21
  4. Item 4: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    92 vote records from 53 filers. 45 of the 49 filers that marked the item voted against management. 4 filers gave no management mark.

    • Positions of 26 fund families
    • For 1
    • Against 25
    • Against management 24

Positions of the fund families

No single ballot item here has the position of a fund family. Director elections and grouped items are not in this table.

Questions

How many filers reported votes at the Prime Medicine, Inc. meeting?
55 Form N-PX filers reported votes at the meeting of 1 Aug 2025.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Prime Medicine, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Prime Medicine, Inc. with a meeting date within three days of 1 Aug 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .